Drug Interactions between Baraclude and Tyzeka
This report displays the potential drug interactions for the following 2 drugs:
- Baraclude (entecavir)
- Tyzeka (telbivudine)
Interactions between your drugs
No interactions were found between Baraclude and Tyzeka. This does not necessarily mean no interactions exist. Always consult your healthcare provider.
- Baraclude is in the drug class nucleoside reverse transcriptase inhibitors (NRTIs).
- Baraclude is used to treat Hepatitis B.
- Tyzeka is in the drug class nucleoside reverse transcriptase inhibitors (NRTIs).
- Tyzeka is used to treat Hepatitis B.
Drug and food interactions
Applies to: Baraclude (entecavir)
You may experience reduced absorption of entecavir in the presence of food. Take entecavir on an empty stomach 2 hours before or 2 hours after a meal unless otherwise directed by your doctor. This will make it easier for your body to absorb the medication. It is important to take entecavir regularly to get the most benefit.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.